Optimized penile surface mold brachytherapy using latest stereolithography techniques: A single-institution experience.

PURPOSE To describe a technique of penile surface mold high-dose-rate (HDR) brachytherapy and early outcomes. METHODS AND MATERIALS Five patients diagnosed with a T1aN0 squamous cell carcinoma of the penis were treated using a penile surface mold HDR brachytherapy technique. A negative impression of the penis was obtained using dental alginate. CT images were acquired of the penile impression; subsequently, a virtual model of the patient's penis was generated. The positive model was imported into a computer-assisted design program where catheter paths were planned such that an optimized offset of 5 mm from the penile surface was achieved. The virtual model was converted into a custom applicator. A total dose of 40 Gy was delivered in 10 fractions. Patients were followed at 1, 3, 6, and 12 months after treatment and then every 6 months thereafter. Toxicities were reported using Common Terminology Criteria for Adverse Events v4.0. RESULTS All patients tolerated treatment well. Acute Grade 2 skin reactions were observed within the first month after treatment. Median followup was 35 months. Late Grade 1 skin toxicities were observed. One patient experienced a urethral stricture requiring dilatation. Two patients developed local recurrence. CONCLUSION This technique allows the delivery of penile HDR brachytherapy as an outpatient procedure with minimal discomfort to the patient during each application and is a repeatable and accurate setup. This technique warrants validation in larger series with longer followup.

[1]  C. Haie-meder,et al.  Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  G. Pond,et al.  Penile brachytherapy: results for 49 patients. , 2005, International journal of radiation oncology, biology, physics.

[3]  S. Minhas,et al.  Organ-sparing Treatment for Penile Cancer , 2018, European Urology Supplements.

[4]  H. van Tinteren,et al.  Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system. , 1994, The Journal of urology.

[5]  F. Algaba,et al.  EAU penile cancer guidelines 2009. , 2010, European urology.

[6]  J. Dillner,et al.  Penile cancer: epidemiology, pathogenesis and prevention , 2009, World Journal of Urology.

[7]  S. Fosså,et al.  Quality of life in patients treated for penile cancer. A follow-up study. , 1994, British journal of urology.

[8]  C. Haie-meder,et al.  Brachytherapy for Conservative Treatment of Invasive Penile Carcinoma: Prognostic Factors and Long-Term Analysis of Outcome. , 2017, International journal of radiation oncology, biology, physics.

[9]  R. Sarin,et al.  Treatment results and prognostic factors in 101 men treated for squamous carcinoma of the penis. , 1997, International journal of radiation oncology, biology, physics.

[10]  Harry Easton,et al.  Customized vaginal vault brachytherapy with computed tomography imaging-derived applicator prototyping. , 2015, Brachytherapy.

[11]  A. Gerbaulet,et al.  Radiation therapy of cancer of the penis. Indications, advantages, and pitfalls. , 1992, The Urologic clinics of North America.

[12]  S. Das,et al.  Penile amputations for the management of primary carcinoma of the penis. , 1992, The Urologic clinics of North America.

[13]  J. Łyczek,et al.  Penile cancer brachytherapy HDR mould technique used at the Holycross Cancer Center , 2011, Journal of contemporary brachytherapy.

[14]  S. Fosså,et al.  Sexuality in patients treated for penile cancer: patients' experience and doctors' judgement. , 1994, British journal of urology.

[15]  C. Haie-meder,et al.  American Brachytherapy Society-Groupe Européen de Curiethérapie-European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy. , 2013, Brachytherapy.